CFAI
C.F.A.I.
Government Data Intelligence Services

MYLAN INC

Company PR
Found in 4 federal databases · 11 total records
Department of Justice 2 records
DOJ: Mylan Agrees to Pay $465 Million to Resolve False Claims Act Liability 2017-08-17
BOSTON – The U.S. Attorney’s Office announced today that pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve allegations that they violated the Fals...
View Source
DOJ: Mylan Agrees to Pay $465 Million to Resolve False Claims Act Liability for Underpaying EpiPen Rebates 2017-08-17
Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen as a generic d...
View Source
EPA (Environmental Protection Agency) 1 records
EPA TRI: MYLAN INC
TRI facility in CAGUAS, PR (CAGUAS MUNICIPIO County)
View Source
fda 5 records
FDA Drug Recall: Temozolomide Capsules, 100 mg, packaged in a) 5-count bottles (NDC 0378-5262-98) 2017-02-01
Class II — Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
View Source
FDA Drug Recall: Temozolomide Capsules, 250 mg, 5-count bottles, Rx only, Mylan Pharmaceuticals, 2017-02-01
Class II — Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
View Source
FDA Drug Recall: Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-98) 2017-02-01
Class II — Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
View Source
FDA Drug Recall: Temozolomide Capsules, 140 mg, packaged in a) 5-count bottles (NDC 0378-5263-98) 2017-02-01
Class II — Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
View Source
FDA Drug Recall: Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceutic 2012-12-05
Class II — Failed USP Content Uniformity Requirements: OOS result reported on retained samples.
View Source
ftc_enforcement 1 records
Mylan Inc., Agila Specialties Global Pte.Limited, Agila Specialties Private Limited, and Strides Arcolab Limited, In the Matter of 2013-12-18
FTC live enforcement action FY2013; matched respondent 'Mylan Inc., Agila Specialties Global Pte.Limited, Agila Specialties Private Limited'
View Source
ny_corps 2 records
NY Corp: MYLAN INC. 2011-08-17
FOREIGN BUSINESS CORPORATION | County: New York | Jurisdiction: Pennsylvania
View Source
NY Corp: MYLAN ASSOCIATES, LLC 2004-10-08
DOMESTIC LIMITED LIABILITY COMPANY | County: Richmond | Jurisdiction: New York
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.